Remove 2030 Remove Diabetes Remove Vaccines
article thumbnail

mRNA licensing agreements rise 800% in value as confidence grows beyond vaccines

Express Pharma

Messenger ribonucleic acid (mRNA)-based innovator pharmaceuticals saw a staggering 800 per cent increase in licensing agreement deal values from 2019 to 2024YTD, driven by the remarkable success of mRNA vaccines during the COVID-19 pandemic. billion in 2030. Bristol Myers Squibb formed a multi-year, $1.87

Vaccines 104
article thumbnail

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Pharmacy Times

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more

STAT

We accept all manner of confidential communications and secret dossiers … New diabetes and weight loss drugs may benefit patients undergoing hip replacement without adding to complication risks , Reuters reports, citing preliminary data released at a meeting of orthopedic surgeons.

Diabetes 290
article thumbnail

Pharmacies Need Strategies to Improve Health Care Access

Pharmacy Times

The Healthy People 2030 initiative addresses structural health care inequalities and implements programs to ameliorate SDOH. Each unique set of economic, educational, social, and environmental circumstances significantly affects their quality of life and health.

article thumbnail

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Times

CAR T-cell therapies dominate the genetically modified space, targeting cancer in 97% of cases, while non-genetically modified therapies focus on regenerative medicine. Technological advances, such as CRISPR-Cas9 and in vivo cell engineering, are addressing challenges like short-term cell persistence and antigen escape.

article thumbnail

Driving drug innovation: developments in pharmaceutical capsules

European Pharmaceutical Review

billion market by 2030, growing from a 2020 value of around $2.4 Dr Bhat : Chronic diseases where FDCs are employed include hypertension, diabetes, Human Immunodeficiency Virus (HIV) and tuberculosis (TB). New types of drugs, such as oral vaccines, will also be formulated as capsules. About the author. GlobeNewswire News Room.

Dosage 124
article thumbnail

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Pharmacy Times

2019;380:2020-2030. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med.